(MENAFN- Khaleej Times)
Published: Mon 17 Jan 2022, 3:56 PM
The UAE has administered 17,892 doses of the Covid-19 vaccine in the past 24 hours.
The country's Ministry of Health and Prevention (MoHAP) said the total doses administered now stand at 23.1 million.
This takes the rate of doses to 233.65 doses per 100 people.
India's Gennova Biopharmaceuticals is working on an Omicron-specific Covid-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.
The source, who did not want to be named as the information was private, said the product might need a small trial in India before it could be rolled out as a booster or standalone vaccine.
A representative for Gennova, a unit of drugmaker Emcure Pharmaceuticals that does business in some 70 countries, did not immediately respond to a request for comment.
Pfizer Inc said last week a redesigned Covid-19 vaccine that specifically targets the Omicron coronavirus variant could be ready to launch by March.
Meanwhile, Novak Djokovic could be barred from playing in the French Open as things stand now after the Sports Ministry said on Monday there would be no exemption from France's new vaccine pass law.
World number one Djokovic, who has not been vaccinated against Covid-19 , was deported from Australia on Sunday before the first Grand Slam tournament of the year after losing a court case to have the cancellation of his visa overturned.
France's vaccine pass law, approved by parliament on Sunday, will require people to have a certificate of vaccination to enter public places such as restaurants, cafes, cinemas and long-distance trains.
'The rule is simple. The vaccine pass will be imposed, as soon as the law is promulgated, in establishments that were already subject to the health pass,' the ministry said.
MENAFN17012022000049011007ID1103551478
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.